핵의학

본문글자크기
  • [Clin Endocrinol (Oxf).] BRAF-positive multifocal and unifocal papillary thyroid cancer show different messenger RNA expressions.

    중앙의대, 부산의대 / 박경준, 석주원*, 김윤학*

  • 출처
    Clin Endocrinol (Oxf).
  • 등재일
    2019 Apr
  • 저널이슈번호
    90(4):601-607. doi: 10.1111/cen.13928. Epub 2019 Jan 25.
  • 내용

    바로가기  >

    Abstract
    OBJECTIVE:
    Thyroid cancer is the most common malignant endocrine tumour, and its incidence has continuously increased worldwide over the past three decades. We focused on the association of multifocal papillary thyroid carcinoma (PTC) with messenger RNA (mRNA) expression to characterize how molecular and histopathologic features relate to multifocality.

    DESIGN:
    A retrospective cohort study.

    PATIENTS:
    The primary and processed data were downloaded from The Cancer Genome Atlas. A total of 490 patients were included in this study.

    METHODS:
    The statistical significance of differences in sex, age, histology, LN metastasis and recurrence were analysed using chi-squared test. To identify differentially expressed genes between BRAF (+) multifocal and unifocal PTCs and between BRAF (-) multifocal and unifocal PTCs, we used the Significance Analysis of Microarray. Over-representation analysis is conducted using CPDB.

    RESULTS:
    A total of 237 patients had BRAF (+) PTCs, whereas 253 had BRAF (-) PTCs. There were 110 patients with multifocal PTCs and 127 with unifocal PTCs in the BRAF (+) group and 116 patients with multifocal PTCs and 137 with unifocal PTCs in the BRAF (-) group. In BRAF (+) group, multifocal PTCs had increased expression of 158 mRNAs as compared to that in unifocal PTCs. Ten mRNAs were involved in Wnt-related pathways, and seven mRNAs were included in pluripotency-related pathways.

    CONCLUSION:
    Multifocal PTCs have higher expression of mRNAs in Wnt- and pluripotency-related pathways when BRAF mutation is present. This might be the mechanism that accounts for the difference between multifocal and unifocal PTCs.

     


    Author information

    Pak K1, Suh S2, Goh TS3, Kim SJ4, Oh SO5, Seok JW6, Kim IJ1, Kim YH7,8.
    1
    Department of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
    2
    Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea.
    3
    Department of Orthopaedic Surgery and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
    4
    Department of Nuclear Medicine and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Korea.
    5
    Department of Anatomy, School of Medicine, Pusan National University, Yangsan, Korea.
    6
    Department of Nuclear Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
    7
    Department of Anatomy and Biomedical Informatics, School of Medicine, Pusan National University, Yangsan, Korea.
    8
    Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.

  • 키워드
    messenger RNA; multifocality; thyroid cancer
  • 덧글달기
    덧글달기
       IP : 18.218.184.214

    등록